Allergan, Inc. (AGN) Tops Q2 EPS by 2c; Guides FY13 Sales, EPS
Tweet Send to a Friend
Allergan, Inc. (NYSE: AGN) reported Q2 EPS of $1.22, $0.02 better than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
